626-03-9 = 89282-12-2 反应条件:1.1 Reagents: Sulfuric Acid; 0 °C -> 20 °C; 35 Min,20 °C1.2 Reagents: Fuming Nitric Acid; 4.5 H,< 5 °C 标题:Process Development And Multikilogram-Scale Synthesis Of A Trpv1 Antagonist 作者:Cleator,Ed; Scott,Jeremy P.; Avalle,Paulo; Bio,Matthew M.; Brewer,Sarah E.; Et Al 参考文献:Organic Process Research & Development 日期:2013 卷标:17(12) 页码:1561-1567]
626-03-9 = 89282-12-2 反应条件:1.1 Reagents: Nitric Acid Solvents: Water; 10 Min,80 °C 标题:Synthesis And Structure-Activity Relationships Of Pyrido[3,2-B]Pyrazin-3(4H)-Ones And Pteridin-7(8H)-Ones As Corticotropin-Releasing Factor-1 Receptor Antagonists 作者:Dzierba,Carolyn D.; Sielecki,Thais M.; Arvanitis,Argyrios G.; Galka,Amy; Johnson,Tricia L.; Et Al 参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2012 卷标:22(15) 页码:4986-4989]
626-03-9 = 89282-12-2 反应条件:1.1 Reagents: Sulfuric Acid,Nitric Acid1.2 Solvents: Water 标题:Structure-Activity Relationships Of A Series Of Pyrrolo[3,2-D]Pyrimidine Derivatives And Related Compounds As Neuropeptide Y5 Receptor Antagonists 作者:Norman,Mark H.; Chen,Ning; Chen,Zhidong; Fotsch,Christopher; Hale,Clarence; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2000 卷标:43(22) 页码:4288-4312]
626-03-9 = 89282-12-2 反应条件:1.1 Reagents: Sulfuric Acid,Nitric Acid; 0 °C 标题:Regioselective Coupling Reactions Of 2,4-Diaminopyridine Derivatives With Aryl Halides: The Synthesis Of Elaborated Pyridines 作者:Bio,Matthew M.; Cleator,Ed; Davies,Antony J.; Hamilton,Simon E.; Lawrence,Andrew; Et Al 参考文献:Tetrahedron 日期:2009 卷标:65(44) 页码:8950-8955]
626-03-9 = 89282-12-2 反应条件:1.1 Reagents: Nitric Acid 标题:1-Deazaadenine (7-Aminoimidazo[b]Pyridine). I. Deazapurine Derivatives 作者:Kogl,F.; Van Der Want,G. M.; Salemink,C. A. 参考文献:Recueil Des Travaux Chimiques Des Pays-Bas Et De La Belgique 日期:1948 卷标:67 页码:29-44]
626-03-9 = 89282-12-2 反应条件:1.1 Reagents: Sulfuric Acid,Nitric Acid Solvents: Water; 30 Min,0 °C; 0.5 H,0 °C1.2 Solvents: Water; 1 H,0 °C 标题:Scaffold Morphing Leading To Evolution Of 2,4-Diaminoquinolines And Aminopyrazolopyrimidines As Inhibitors Of The Atp Synthesis Pathway 作者:Tantry,Subramanyam J.; Shinde,Vikas; Balakrishnan,Gayathri; Markad,Shankar D.; Gupta,Amit K.; Et Al 参考文献:Medchemcomm 日期:2016 卷标:7(5) 页码:1022-1032]
52809-57-1 = 89282-12-2 反应条件:1.1 Reagents: Nitric Acid 标题:Preparation Of 2,4-Dihydroxypyridine N-Oxide 作者:Talik,Tadeusz; Talik,Zofia 参考文献:Prace Naukowe Akademii Ekonomicznej Imienia Oskara Langego We Wroclawiu 日期:1985 卷标:313 页码:115-19
专利号:EP-0609960-B1 优先权日:1989-09-15 标 题 :New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase 发明人:MCCARTHY PETER A; HAMANAKA ERNEST S; WALKER FREDERICK J; CHANG GEORGE; TRUONG THIEN 权利人:PFIZER 摘要:Compounds of the formula the pharmaceutically acceptable salts thereof, wherein Q and R<1> are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
专利号:US-5656634-A 优先权日:1991-03-21 标题 :N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) 发明人:CHANG GEORGE; HAMANAKA ERNEST S; MCCARTHY PETER A; TRUONG THIEN V; WALKER FREDERICK J 权利人:PFIZER 摘要:Compounds of the formula ##STR1## the pharmaceutically acceptable salts thereof, wherein Q and R 1 are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
专利号:US-2009012088-A1 优先权日:2005-07-26 标 题:Compounds for the Treatment of Neurodegeneration and Stroke 发明人:HERGENROTHER PAUL J; PUTT KARSON S; LIU XIANJUN 权利人:HERGENROTHER PAUL J; PUTT KARSON S; LIU XIANJUN 摘要:Compounds and related methods for synthesis, and the use of compounds for the treatment of neurodegenerative diseases are disclosed. Compounds are disclosed in connection with PARG and/or PARP inhibition. Therapeutic applications are relevant for preventing or inhibiting neurological cell death for a variety of neurodegenerative conditions including Parkinson's disease, ischemia, and stroke. Also disclosed is a high-throughput screen for identifying compounds capable of inhibiting PARG and/or PARP.
专利号:US-5596001-A 优先权日:1993-10-25 标题 :4-aryl-3-(heteroarylureido)quinoline derivatves 发明人:HAMANAKA ERNEST S 权利人:PFIZER 摘要:Compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 , m, X and Q are as defined below, and novel intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and natiatherosclerosis agents.